Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Euro Orphan Drugs 2018

About Conference

Conference Series is proud to host the 8th World congress on Rare Diseases & Orphan Drugs (Euro Orphan Drugs 2018) during November 21-22, 2018 at Paris-France. This upcoming European Orphan Drug Conference is designed on the theme “Challenges & Opportunities in Orphan Drugs Development: Commercialisation, Policies, Reimbursement, and Pricing “.

This Rare Diseases & Orphan Drugs Conference aims to provide the best platform to all the researchers working in Rare Diseases & Orphan Drugs Research, Orphan Drugs developers, Healthcare sector, regulatory & health authorities, patient organisations, patient advocacy, Clinical Trials & Research, and public policy individuals.

This Orphan Drugs & Rare Diseases Congress 2018 Europe will offer a proper platform will provide a unique platform for all the stakeholders in the Orphan Drug Industry sector to discuss current issues, trends and innovations in Rare Diseases Research & Orphan Drugs development and to network with hospitals, Research labs, Pharma-Biopharma Companies, Orphan Drugs developers, and non-profit organizations etc.

This Orphan Drugs Congress 2018 composed of extended scientific sessions, Plenary sessions, Oral Presentations, Industry oriented sessions, Poster Presentations, Exhibitor sessions, Workshops, Symposiums, Young Research Forums, Videos Presentations and e-Poster Presentations etc.


Who Should Attend

The Euro Orphan Drugs 2018 Conferences  bring together the senior level attendees and speakers from both academia, clinical research institutes, Clinical laboratories, Hospitals and from the top Biopharmaceutical companies from across the globe. Participants includes Directors, Deans, Research Professors, VPs, CTOs, Laboratory heads, Drug Developers, Clinical Trials Researchers, clinical trials sponsors, CROs, Medical doctors, & Researchers working in the sector of:

  • Drug Discovery & Development
  • Personalized, Translational, Experimental, & Regenerative Medicine
  • Clinical Trials & Clinical Research
  • Rare & ultra-rare Diseases
  • Genetic Diseases
  • Targeted Therapy, Cell & Gene Therapy
  • Molecular Diagnostics & Diagnostic Product developers
  • Patient Advocacy, Market Access, Pricing & Reimbursement
  • In-Licensing/Out-Licensing
  • Regulatory & Medical Affairs
  • Commercial Development of Drugs
  • Health Economics/Outcomes Research (HEOR)
  • Orphan Foundations/Associations
  • Experts working in Big Data & Digital Health
  • Oncologist and Cancer experts
  • Immunology & Inflammatory Disease
  • Other Rare Disease & Therapy areas of: Neurology, mental health, neuromuscular disorders,

Why Attend

This two days of Orphan Drugs Congress will offer an interactive and most compressive sessions & networking with global experts working in the Rare Disease & Orphan Drugs segment. Orphan Drugs 2018 Paris Congress will help in gaining insights & to upgrade knowledge towards current activities growing globally in the Orphan Drugs sector starting from Laboratory research to field research, clinical trials to orphan drugs development, pricing and reimbursement, commercialization of orphan drugs & regulatory policies etc.

Orphan Drugs 2018 comprises of well organized scientific program stuffed with interactive sessions, one to one discussion rounds, industry academia interaction programs, industrials presentations, special regulatory sessions, and networking sessions.

Get Insights of:

Major Sessions

  • Overview of Rare Diseases & Orphan Drugs
  • Types of Rare Diseases
  • Genetic Rare Diseases
  • FDA approval process of Orphan Drugs Products
  • Challenges in Rare Diseases Diagnosis
  • Rare Diseases Treatment Landscape
  • Orphan Drug Pricing Reimbursement and Patient Access
  • Ethical issues in Funding Orphan Drugs Research and Development
  • Orphan Drugs Development Barriers
  • Orphan Drugs Development: Current Trends & Future
  • Clinical Trials & Clinical Research in Rare Diseases & Orphan Drugs
  • Patient Concerns on Orphan Drugs
  • Legislation & Regulatory policies in Orphan Drugs & Rare Disease Research
  • Funding Opportunities in Rare Disease & Orphan Drugs Research
  • Economical Perspective in Rare Diseases
  • Designating Orphan Products: Drugs and Biologicals
  • Developing Products for Rare Diseases & Conditions

To Collaborate Scientific Professionals around the World

Conference Date Nov 21-22, 2018

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

Journal of Rare Disorders: Diagnosis & Therapy Journal of Genetic Syndromes & Gene Therapy International Journal of Drug Development and Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos